John De Vos
LightNews LightNews
banner
jdevos.bsky.social
John De Vos
@jdevos.bsky.social
330 followers 370 following 220 posts

#StemCells Researcher | Director of the Cell Processing Facility
University of Montpellier - CHU of Montpellier | #StemCells #iPScells for #lung #CellTherapy |
Stem Genomics co-founder | President of the FSSCR

Videos
Biology 37%
Environmental science 10%
Posts Replies Media Videos

Reposted by John De Vos

odedrechavi.bsky.social
Oded Rechavi @odedrechavi.bsky.social · 1d
You and the text you need to trim in order to meet the word limit

Reposted by John De Vos

Reposted by John De Vos

jdevos.bsky.social
John De Vos @jdevos.bsky.social · 5d
✨🔬 Get ready for groundbreaking #StemCell research!
Join us in Lyon, Nov 17–19, 2025, for the 7th #FSSCR Annual Meeting.
Connect with leading experts and be part of inspiring scientific exchanges 👇
👉 buff.ly/FRotkAi

@FSSCR_officiel
#FSSCR2025

jdevos.bsky.social
John De Vos @jdevos.bsky.social · 6d
✨🔬 Exciting #StemCell science ahead!
Join us in Lyon, Nov 17–19, 2025 for the 7th #FSSCR Annual Meeting.
Meet top speakers and take part in inspiring discussions 👇
👉 buff.ly/FRotkAi

@FSSCR_officiel
#FSSCR2025

jdevos.bsky.social
John De Vos @jdevos.bsky.social · 6d
Jennifer Doudna startup launches with $82M to apply new #CRISPR delivery technology to in vivo #CARTCells.

buff.ly/mewzZFL
Jennifer Doudna startup launches with $82M to apply new CRISPR delivery technology to in vivo CAR-T
Nobel laureate Jennifer Doudna's Azalea Therapeutics raises $82M to develop new CRISPR delivery system for in vivo CAR-T cell therapies targeting blood cancers.
endpoints.news

Reposted by John De Vos

Reposted by John De Vos

Reposted by John De Vos

Reposted by Menzie Chinn, John De Vos, Gavin A. Schmidt , and 2 more

pdjeliclark.bsky.social
P. Djéli Clark | The Disgruntled Haradrim @pdjeliclark.bsky.social · 10d
Happy Halloween
Halloween gravestone reading “I Did My Own Research” in a yard with two skeleton arms sticking out of the grass.

jdevos.bsky.social
John De Vos @jdevos.bsky.social · 11d
✨🔬 Get ready for groundbreaking #StemCell research!
Join us in Lyon, Nov 17–19, 2025, for the 7th #FSSCR Annual Meeting.
Connect with leading experts and be part of inspiring scientific exchanges 👇
👉 buff.ly/FRotkAi

@FSSCR_officiel
#FSSCR2025

Reposted by John De Vos

jdevos.bsky.social
John De Vos @jdevos.bsky.social · 14d
#iPSC-derived, off-the-shelf anti-CD19 #CARTcells deliver improved clinical outcomes in lupus.

buff.ly/h2uH87G

jdevos.bsky.social
John De Vos @jdevos.bsky.social · 15d
✨🔬 Exciting #StemCell science ahead!
Join us in Lyon, Nov 17–19, 2025 for the 7th #FSSCR Annual Meeting.
Meet top speakers and take part in inspiring discussions 👇
👉 buff.ly/FRotkAi

@FSSCR_officiel
#FSSCR2025

Reposted by John De Vos

Reposted by John De Vos

gdeleur.bsky.social
Guillaume D. @gdeleur.bsky.social · 16d
Le samedi soir, malgré tout, il est pertinent – voire évident – de poster du Tom Gauld. www.tomgauld.com (description et traduction en cliquant sur ALT).
Case 1 : Une silhouette se tient debout derrière un pupitre et dit : « Cette image illustre ma théorie selon laquelle, face à une quantité suffisante de formules complexes, de diagrammes alambiqués et d'acronymes incompréhensibles, un public sera prêt à adhérer à presque n'importe quoi. » L'écran est entièrement recouvert de ce genre d'éléments Cases 2, 3, 4 et 5. Quatre membres du public s'exclament avec enthousiasme : « C'est exactement ce que je pense ! », « Tout à fait d'accord ! », « Je suis tout à fait d'accord ! » et « Excellent argument ! ».

jdevos.bsky.social
John De Vos @jdevos.bsky.social · 17d
Une analyse équilibrée, pertinente et solidement argumentée sur la place de l’IA dans l’enseignement supérieur. Une lecture incontournable. (Les militaires ont plein de choses à nous apprendre!)
A Guide to Collaborating With AI in the Military Classroom
If educators do not learn to embrace AI, they risk being left behind. Yet the question before professional military education institutions is not whether
buff.ly

jdevos.bsky.social
John De Vos @jdevos.bsky.social · 17d
✨🔬Great #StemCell research. Come, discuss, join us in Lyon Nov 17-19, 2025 at the 7th #FSSCR annual meeting. Outstanding talks, see speakers: 👉https://buff.ly/FRotkAi
📆 Regular rates available until 19 Oct 2025
@FSSCR_officiel
#FSSCR2025

Reposted by John De Vos

Reposted by Joanna Bryson, Steven L. Salzberg, Lisa W. Fazio , and 49 more

jbenmenachem.com
jon ben-menachem @jbenmenachem.com · 20d
Wow. Harvard nuking its PhD programs

- Science PhD admissions reduced by more than 75%
- Arts & Humanities reduced by about 60%
- Social Sciences by 50–70%
- History by 60%
- Biology by 75%
- The German department will lose all PhD seats
- Sociology from six PhD students to zero
Harvard FAS Cuts Ph.D. Seats By More Than Half Across Next Two Admissions Cycles | News | The Harvard Crimson
The Faculty of Arts and Sciences slashed the number of Ph.D. student admissions slots for the Science division by more than 75 percent and for the Arts & Humanities division by about 60 percent for th...
www.thecrimson.com

jdevos.bsky.social
John De Vos @jdevos.bsky.social · 20d
Galapagos exits the cell therapy field, joining other recent high-profile departures such as Novo Nordisk and Takeda. Tough times for the sector.

buff.ly/x1igaTU

jdevos.bsky.social
John De Vos @jdevos.bsky.social · 21d
Anti-BCMA #CARTells therapy in patients with progressive multiple sclerosis. Encouraging phase I study in 5 patients.
via @CellCellPress

buff.ly/tK6QG6D